Definitive Contract 75D30118C02888

This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is an agency-wide Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle with the Department of Health and Human Services Indian Health Service, with a potential value of $136,000.00. The contract is for the delivery of diagnostic equipment, reagents, and consumables to support the clinical diagnostic programs of...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for GENEXPERT IV. The contract has a potential value of $118,086.25 and a completion date of October 4, 2019. As the original equipment manufacturer, Cepheid provides a range of goods and services related to diagnostic testing equipment, reagents, and consumables, as well as associated...

This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to the National Institute For Scientific And Industrial Research, a non-profit organization, on September 18, 2017. The contract, which does not have a set-aside designation, is for critical functions with a potential value of $147,000.00. The period of performance for this contract is through January 17, 2019, and the place of performance is in Atlanta,...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...

The Department of Health and Human Services Indian Health Service awarded a delivery order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The $60,384.00 contract is for the additional procurement of Cepheid's 4Plex+ COVID-19 testing offering. This award is part of a larger agency-wide Indefinite Delivery, Indefinite Quantity (IDIQ) contract with Cepheid. The contract is a firm fixed price agreement and does...

This federal contract award is for services provided by The Center For Disease Dynamics Economics & Policy Inc. (CDDEP), a non-profit organization, to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a potential value of $123,572.95 and is a firm fixed price delivery order,...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $205,470.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, which is not set aside, is for the provision of reagents, test kits, instruments, and testing platforms to support the CDC's clinical diagnostic programs. Cepheid, as the prime contractor, has a...

The Department of Health and Human Services Indian Health Service awarded a firm fixed price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, known as the CEPHEID IDIQ COVID-19 4 PLEX, is valued at up to $272,000.00 and has a completion date of June 8, 2023. Cepheid will provide reagents, test kits, instruments, and testing platforms to support the Indian Health Service's clinical diagnostic programs. This is an indefinite delivery,...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) Indian Health Service (IHS) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract is for the purchase of Cepheid XP3COV2/FLU/RSV-10 test kits to be delivered by September 30, 2024. The potential value of the contract is $174,080.00. The award does not have a set-aside designation. Cepheid has been awarded numerous prime...